BYDUREON

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug BYDUREON contains one active pharmaceutical ingredient (API):

1	Exenatide UNII 9P1872D4OL - EXENATIDE
	Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that exhibits several antihyperglycaemic actions of glucagon-like peptide-1 (GLP-1). The amino acid sequence of exenatide partially overlaps that of human GLP-1. Exenatide has been shown to bind to and activate the known human GLP-1 receptor in vitro, its mechanism of action mediated by cyclic AMP and/or other intracellular signalling pathways. Exenatide increases, on a glucose-dependent basis, the secretion of insulin from pancreatic beta cells.
	Read more about Exenatide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BJ01	Exenatide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10888C
CA	Health Products and Food Branch	02448610
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1152-MEE-0715
EE	Ravimiamet	1533787, 1533798, 1778902, 1802304
ES	Centro de información online de medicamentos de la AEMPS	111696003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	088891, 514501
FR	Base de données publique des médicaments	66105532
GB	Medicines & Healthcare Products Regulatory Agency	284261, 375913, 380606
HK	Department of Health Drug Office	64579, 66530
IE	Health Products Regulatory Authority	13106, 54347
IL	מִשְׂרַד הַבְּרִיאוּת	7354
LT	Valstybinė vaistų kontrolės tarnyba	1061235, 1061236, 1076648, 1076649, 1086385, 1088387
NL	Z-Index G-Standaard	16137841
NL	Z-Index G-Standaard, PRK	125636
NZ	Medicines and Medical Devices Safety Authority	17293
PL	Rejestru Produktów Leczniczych	100252744
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64922001
SG	Health Sciences Authority	15095P
US	FDA, National Drug Code	0310-6530, 0310-6540